Levosimendan infusion in newborns after corrective surgery for congenital heart disease: Randomized controlled trial

Intensive Care Medicine

Volumn 38, Issue 7, 2012, Pages 1198-1204

  Ricci, Zaccaria ^a   Garisto, Cristiana ^a   Favia, Isabella ^a   Vitale, Vincenzo ^a   Di Chiara, Luca ^a   Cogo, Paola E ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Cardiopulmonary bypass; Congenital heart disease; Inodilator; Levosimendan; Low cardiac output syndrome; Pediatric cardiac surgery

Indexed keywords

LACTIC ACID; LEVOSIMENDAN;

ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP HYPOTHERMIC CIRCULATORY ARREST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FORWARD HEART FAILURE; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HEART SURGERY; HUMAN; LENGTH OF STAY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; SURGICAL RISK;

CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; HEART DEFECTS, CONGENITAL; HUMANS; HYDRAZONES; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; ITALY; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PYRIDAZINES;

EID: 84862637271     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2564-6     Document Type: Article

References (26)

1. Andropoulos DB, Ogletree ML (2005) Physiology and molecular biology of the developing circulation. In: Andropoulos DB, Stayer SA, Russell IA (eds) Anesthesia for congenital heart disease. Blackwell Futura, Madden, pp 30-45
2. EA Buijs AH Danser NI Meijer D Tibboel 2011 Cardiovascular catecholamine receptors in children: their significance in cardiac disease J Cardiovasc Pharmacol 58 9 19 21654329 10.1097/FJC.0b013e31822233dd 1:CAS:528: DC%2BC3MXoslOqtLk%3D
3. Artman M, Mahoney L, Teidel DF (2001) Regulation of myocyte contraction and relaxation. In: Artman M, Mahoney L, Teidel DF (eds) Neonatal cardiology. McGraw Hill, New York, pp 19-37
4. N Than N Shah J White JA Lee CH Orchard 1994 Effects of acidosis and hypoxia on the response of isolated ferret cardiac muscle to inotropic agents Cardiovasc Res 28 1209 1217 7954624 10.1093/cvr/28.8.1209 1:CAS:528: DyaK2cXmslWktLs%3D
5. JL Jefferies TM Hoffman DP Nelson 2010 Heart failure treatment in the intensive care unit in children Heart Fail Clin 6 531 558 20869652 10.1016/j.hfc.2010.06.001
6. JS Tweddell GM Hoffman 2002 Postoperative management in patients with complex congenital heart disease Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5 187 205 11994879 10.1053/pcsu.2002.31499
7. TM Hoffman G Wernovsky AM Atz TJ Kulik DP Nelson AC Chang JM Bailey A Akbary JF Kocsis R Kaczmarek TL Spray DL Wessel 2003 Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease Circulation 107 996 1002 12600913 10.1161/01.CIR.0000051365.81920.28 1:CAS:528:DC%2BD3sXjt1yjsrc%3D
8. DJ Milligan AM Fields 2010 Levosimendan: calcium sensitizer and inodilator Anesthesiol Clin 28 753 760 21074750 10.1016/j.anclin.2010.08.003 1:CAS:528:DC%2BC3cXhsVWmtLfO
9. Bonios MJ, Terrovitis JV, Drakos SG, Katsaros F, Pantsios C, Nanas SN, Kanakakis J, Alexopoulos G, Toumanidis S, Anastasiou-Nana M, Nanas JN (2011) Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. Int J Cardiol. doi: 10.1016/ij.card.2011.03.013
10. Lahtinen P, Pitkänen O, Pölönen P, Turpeinen A, Kiviniemi V, Uusaro A (2011) Levosimendan reduces heart failure after cardiac surgery- a prospective, randomized, placebo-controlled trial. Crit Care Med. doi: 10.1097/CCM.0b013e3182227b97
11. L Tritapepe V De Santis D Vitale M Santulli A Morelli I Nofroni PE Puddu M Singer P Pietropaoli 2006 Preconditioning effects of levosimendan in coronary artery bypass grafting-a pilot study Br J Anaesth 96 694 700 16595616 10.1093/bja/ael082 1:CAS:528:DC%2BD28Xks1Slu7s%3D
12. P Namachivayam DS Crossland WW Butt LS Shekerdemian 2006 Early experience with levosimendan in children with ventricular dysfunction Pediatr Crit Care Med 7 445 448 16885788 10.1097/01.PCC.0000235251.14491.75
13. CF Stocker LS Shekerdemian MA Nørgaard CP Brizard JP Mynard SB Horton DJ Penny 2007 Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass Crit Care Med 35 252 259 17133188 10.1097/01.CCM.0000251123.70632.4E 1:CAS:528: DC%2BD2sXjtVei
14. H Haikala IB Linden 1995 Mechanisms of action of calcium-sensitizing drugs J Cardiovasc Pharmacol 26 S10 S19 8907127 1:CAS:528:DyaK28Xhtlentbo%3D
15. J Lilleberg V Ylonen L Lehtonen L Toivonen 2004 The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies Scand Cardiovasc J 38 80 84 15204232 10.1080/14017430410025783 1:CAS:528:DC%2BD2cXkvFCgtLw%3D
16. D Kopustinskiene P Pollesello N Saris 2001 Levosimendan is a mitochondrial KATP channel opener Eur J Pharmacol 428 311 314 11689188 10.1016/S0014-2999(01)01350-4 1:CAS:528:DC%2BD3MXnvFCqsbc%3D
17. P Pollesello A Mebazaa 2004 ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction Curr Opin Crit Care 10 436 441 15616383 10.1097/01.ccx.0000145099.20822.19
18. PE Soeding CF Royse CE Wright AG Royse JA Angus 2007 Inoprotection: the perioperative role of levosimendan Anaesth Intensive Care 35 845 862 18084975 1:STN:280:DC%2BD2sjkvVCmuw%3D%3D
19. KJ Jenkins K Gauvreau JW Newburger TL Spray JH Moller LI Iezzoni 2002 Consensus-based method for risk adjustment for surgery for congenital heart disease J Thorac Cardiovasc Surg 123 110 118 11782764 10.1067/mtc.2002.119064
20. MG Gaies JG Gurney AH Yen ML Napoli RJ Gajarski RG Ohye JR Charpie JC Hirsch 2010 Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass Pediatr Crit Care Med 11 234 238 19794327 10.1097/PCC.0b013e3181b806fc
21. AL Graciano JA Balko DS Rahn N Ahmad BP Giroir 2005 The Pediatric Multiple Organ Dysfunction Score (P-MODS): development and validation of an objective scale to measure the severity of multiple organ dysfunction in critically ill children Crit Care Med 33 1484 1491 16003052 10.1097/01.CCM. 0000170943.23633.47
22. A Mebazaa MS Nieminen M Packer A Cohen-Solal FX Kleber SJ Pocock R Thakkar RJ Padley P Põder M Kivikko SURVIVE Investigators 2007 Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial JAMA 297 1883 1891 17473298 10.1001/jama.297.17. 1883 1:CAS:528:DC%2BD2sXkvFKrsLs%3D
23. A Tasouli K Papadopoulos T Antoniou I Kriaras G Stavridis D Degiannis S Geroulanos 2007 Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use Eur J Cardiothorac Surg 32 629 633 17702589 10.1016/j.ejcts.2007.07.010
24. V Molina Hazan Y Gonen A Vardi I Keidan D Mishali M Rubinshtein Y Yakov G Paret 2010 Blood lactate levels differ significantly between surviving and nonsurviving patients within the same risk-adjusted classification for congenital heart surgery (RACHS-1) group after pediatric cardiac surgery Pediatr Cardiol 31 952 960 20495912 10.1007/s00246-010-9724-7
25. L Wood M Egger LL Gluud KF Schulz P Jüni DG Altman C Gluud RM Martin AJ Wood JA Sterne 2008 Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study BMJ 336 601 605 18316340 10.1136/bmj.39465.451748.AD
26. TM Hoffman G Wernovsky AM Atz JM Bailey A Akbary JF Kocsis DP Nelson AC Chang TJ Kulik TL Spray DL Wessel 2002 Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study Am Heart J 143 15 21 11773907 10.1067/mhj.2002.120305 1:CAS:528:DC%2BD38XovVOmtQ%3D%3D